Kiniksa Pharmaceuticals International Plc (KNSA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Kiniksa Pharmaceuticals International Plc-Aktie (KNSA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.24% 79.86	83.39	67.05	71.47	48.34
Cost Of Revenue	10.58	-	9.088	7.699	7.036
Gross Profit	69.28	-	57.96	63.77	41.31
Operating Expenses	19.90% 85.82	107.14	68.89	66.93	59.54
Benefits Costs and Expenses	16.29% 94.13	80.94	75.55	72.71	57.71
Costs And Expenses	16.29% 94.13	80.94	75.55	72.71	57.71
Depreciation and Amortization	13.70% 0.466	0.54	0.603	0.602	0.596
Operating Income/Loss	20,522% -16.54	0.081	-10.93	-3.154	-11.20
Income/Loss From Continuing Operations Before Tax	682.69% -14.28	2.45	-8.499	-1.239	-9.364
Income Tax Expense/Benefit, Deferred	116.98% 4.365	-25.71	10.29	-19.44	1.077
Income Tax Expense/Benefit	115.04% 3.428	-22.79	5.356	-16.21	2.906
Income/Loss From Continuing Operations After Tax	170.15% -17.70	25.24	-13.86	14.97	-12.27
Net Income/Loss	170.15% -17.70	25.24	-13.86	14.97	-12.27
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	66,939% 70.63	0.1054	70.19	69.92	69.75
Diluted Average Shares	3,487% 70.63	1.9693	70.19	71.63	69.75
Basic Earnings Per Share	169.44% -0.25	0.36	-0.20	0.21	-0.18
Diluted Earnings Per Share	169.44% -0.25	0.36	-0.20	0.21	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

LNTH

$109.84

0.42%

ITCI

$84.75

0.84%

CTLT

$58.60

0.63%

NBIX

$120.27

3.27%

RDY

$73.90

0.35%

VTRS

$11.60

2.44%